Brief: Fulgent Genetics Q2 Revenue USD 68 Million
04/08/2023 12:00
Aug 04 (Reuters) - Fulgent Genetics Q2 adjusted EBITDA USD -2.7 million. * Q2 core revenue USD 67 million
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview